nodes	percent_of_prediction	percent_of_DWPC	metapath
Nateglinide—ABCC4—Fluorouracil—head and neck cancer	0.27	0.308	CbGbCtD
Nateglinide—CYP2D6—Hydroxyurea—head and neck cancer	0.129	0.147	CbGbCtD
Nateglinide—ALB—Fluorouracil—head and neck cancer	0.1	0.114	CbGbCtD
Nateglinide—CYP3A7—Docetaxel—head and neck cancer	0.082	0.0934	CbGbCtD
Nateglinide—CYP3A7-CYP3A51P—Docetaxel—head and neck cancer	0.082	0.0934	CbGbCtD
Nateglinide—CYP3A5—Docetaxel—head and neck cancer	0.0615	0.07	CbGbCtD
Nateglinide—CYP2C9—Fluorouracil—head and neck cancer	0.054	0.0615	CbGbCtD
Nateglinide—CYP2D6—Vinblastine—head and neck cancer	0.0458	0.0521	CbGbCtD
Nateglinide—CYP3A4—Vinblastine—head and neck cancer	0.0291	0.0331	CbGbCtD
Nateglinide—CYP3A4—Docetaxel—head and neck cancer	0.024	0.0273	CbGbCtD
Nateglinide—Bortezomib—CYP1A1—head and neck cancer	0.000738	1	CrCbGaD
Nateglinide—Gastrointestinal symptom NOS—Hydroxyurea—head and neck cancer	0.00068	0.0927	CcSEcCtD
Nateglinide—Gastrointestinal symptom NOS—Fluorouracil—head and neck cancer	0.000489	0.0667	CcSEcCtD
Nateglinide—Hepatic enzyme increased—Hydroxyurea—head and neck cancer	0.000422	0.0576	CcSEcCtD
Nateglinide—Neuropathy peripheral—Vinblastine—head and neck cancer	0.00024	0.0328	CcSEcCtD
Nateglinide—Neuropathy peripheral—Hydroxyurea—head and neck cancer	0.000219	0.0299	CcSEcCtD
Nateglinide—Hepatobiliary disease—Hydroxyurea—head and neck cancer	0.000211	0.0288	CcSEcCtD
Nateglinide—Osteoarthritis—Fluorouracil—head and neck cancer	0.000209	0.0285	CcSEcCtD
Nateglinide—Upper respiratory tract infection—Fluorouracil—head and neck cancer	0.000168	0.0229	CcSEcCtD
Nateglinide—PPARG—Adipogenesis—STAT3—head and neck cancer	0.000167	0.00146	CbGpPWpGaD
Nateglinide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000162	0.00142	CbGpPWpGaD
Nateglinide—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.00016	0.00141	CbGpPWpGaD
Nateglinide—CYP3A5—Biological oxidations—GSTM1—head and neck cancer	0.000158	0.00139	CbGpPWpGaD
Nateglinide—Neuropathy peripheral—Fluorouracil—head and neck cancer	0.000158	0.0215	CcSEcCtD
Nateglinide—CYP3A5—Metapathway biotransformation—GSTM1—head and neck cancer	0.000156	0.00137	CbGpPWpGaD
Nateglinide—ALB—Folate Metabolism—IL2—head and neck cancer	0.000153	0.00135	CbGpPWpGaD
Nateglinide—CYP3A5—Biological oxidations—CYP1A1—head and neck cancer	0.00015	0.00132	CbGpPWpGaD
Nateglinide—CYP3A4—Biological oxidations—NAT2—head and neck cancer	0.000149	0.00131	CbGpPWpGaD
Nateglinide—CYP3A5—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000148	0.0013	CbGpPWpGaD
Nateglinide—CYP3A4—Metapathway biotransformation—NAT2—head and neck cancer	0.000147	0.00129	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—NAT2—head and neck cancer	0.000147	0.00129	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—NAT2—head and neck cancer	0.000142	0.00125	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—NAT2—head and neck cancer	0.00014	0.00123	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.000137	0.00121	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—UROD—head and neck cancer	0.000132	0.00116	CbGpPWpGaD
Nateglinide—PPARG—Circadian rythm related genes—PTEN—head and neck cancer	0.000132	0.00116	CbGpPWpGaD
Nateglinide—ALB—Selenium Micronutrient Network—PTGS2—head and neck cancer	0.000131	0.00115	CbGpPWpGaD
Nateglinide—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000131	0.00115	CbGpPWpGaD
Nateglinide—ABCC4—Platelet activation, signaling and aggregation—IL2—head and neck cancer	0.000129	0.00113	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—DPYD—head and neck cancer	0.000128	0.00113	CbGpPWpGaD
Nateglinide—Gastrointestinal pain—Vinblastine—head and neck cancer	0.000128	0.0174	CcSEcCtD
Nateglinide—ALB—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.000128	0.00112	CbGpPWpGaD
Nateglinide—Dyspepsia—Hydroxyurea—head and neck cancer	0.000125	0.0171	CcSEcCtD
Nateglinide—KCNJ11—Metabolism—DPYD—head and neck cancer	0.000125	0.00109	CbGpPWpGaD
Nateglinide—Abdominal pain—Vinblastine—head and neck cancer	0.000124	0.0169	CcSEcCtD
Nateglinide—PPARG—Gene Expression—RARB—head and neck cancer	0.000124	0.00108	CbGpPWpGaD
Nateglinide—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.000123	0.0168	CcSEcCtD
Nateglinide—Fatigue—Hydroxyurea—head and neck cancer	0.000123	0.0168	CcSEcCtD
Nateglinide—SLC16A1—Metabolism—DPYD—head and neck cancer	0.000123	0.00108	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—YAP1—head and neck cancer	0.000122	0.00107	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—YAP1—head and neck cancer	0.000118	0.00104	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—YAP1—head and neck cancer	0.000117	0.00102	CbGpPWpGaD
Nateglinide—Hypersensitivity—Vinblastine—head and neck cancer	0.000115	0.0157	CcSEcCtD
Nateglinide—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—head and neck cancer	0.000115	0.00101	CbGpPWpGaD
Nateglinide—ABCC8—Neuronal System—MAPK1—head and neck cancer	0.000115	0.00101	CbGpPWpGaD
Nateglinide—Neuropathy peripheral—Docetaxel—head and neck cancer	0.000114	0.0155	CcSEcCtD
Nateglinide—ALB—Metabolism—UROD—head and neck cancer	0.000114	0.000999	CbGpPWpGaD
Nateglinide—Jaundice—Docetaxel—head and neck cancer	0.000113	0.0154	CcSEcCtD
Nateglinide—CYP2D6—Biological oxidations—GSTM1—head and neck cancer	0.000113	0.000989	CbGpPWpGaD
Nateglinide—PPARG—Gene Expression—YAP1—head and neck cancer	0.000112	0.000987	CbGpPWpGaD
Nateglinide—Asthenia—Vinblastine—head and neck cancer	0.000112	0.0153	CcSEcCtD
Nateglinide—ALB—Platelet degranulation—VEGFA—head and neck cancer	0.000112	0.000982	CbGpPWpGaD
Nateglinide—CYP2C9—Biological oxidations—GSTM1—head and neck cancer	0.000112	0.000981	CbGpPWpGaD
Nateglinide—PPARG—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	0.000112	0.000979	CbGpPWpGaD
Nateglinide—KCNJ11—Neuronal System—MAPK1—head and neck cancer	0.000111	0.000978	CbGpPWpGaD
Nateglinide—CYP2D6—Metapathway biotransformation—GSTM1—head and neck cancer	0.000111	0.000976	CbGpPWpGaD
Nateglinide—PPARG—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	0.00011	0.000969	CbGpPWpGaD
Nateglinide—CYP2C9—Metapathway biotransformation—GSTM1—head and neck cancer	0.00011	0.000967	CbGpPWpGaD
Nateglinide—Hepatobiliary disease—Docetaxel—head and neck cancer	0.00011	0.015	CcSEcCtD
Nateglinide—ABCC4—Platelet activation, signaling and aggregation—VEGFA—head and neck cancer	0.00011	0.000962	CbGpPWpGaD
Nateglinide—Diarrhoea—Vinblastine—head and neck cancer	0.000107	0.0146	CcSEcCtD
Nateglinide—CYP2D6—Biological oxidations—CYP1A1—head and neck cancer	0.000107	0.000938	CbGpPWpGaD
Nateglinide—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—head and neck cancer	0.000106	0.000935	CbGpPWpGaD
Nateglinide—CYP2C9—Biological oxidations—CYP1A1—head and neck cancer	0.000106	0.00093	CbGpPWpGaD
Nateglinide—CYP2D6—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000105	0.000925	CbGpPWpGaD
Nateglinide—PPARG—Generic Transcription Pathway—NOTCH1—head and neck cancer	0.000105	0.000924	CbGpPWpGaD
Nateglinide—Hypersensitivity—Hydroxyurea—head and neck cancer	0.000105	0.0143	CcSEcCtD
Nateglinide—PPARG—Metabolism—NAT2—head and neck cancer	0.000105	0.000922	CbGpPWpGaD
Nateglinide—CYP2C9—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000104	0.000917	CbGpPWpGaD
Nateglinide—ABCC4—Platelet activation, signaling and aggregation—MAPK3—head and neck cancer	0.000104	0.00091	CbGpPWpGaD
Nateglinide—Dizziness—Vinblastine—head and neck cancer	0.000103	0.0141	CcSEcCtD
Nateglinide—Oedema peripheral—Docetaxel—head and neck cancer	0.000103	0.014	CcSEcCtD
Nateglinide—Asthenia—Hydroxyurea—head and neck cancer	0.000102	0.0139	CcSEcCtD
Nateglinide—Vomiting—Vinblastine—head and neck cancer	9.94e-05	0.0136	CcSEcCtD
Nateglinide—PPARG—Developmental Biology—NOTCH1—head and neck cancer	9.9e-05	0.000869	CbGpPWpGaD
Nateglinide—ABCC4—Platelet activation, signaling and aggregation—MAPK1—head and neck cancer	9.86e-05	0.000866	CbGpPWpGaD
Nateglinide—Erythema multiforme—Docetaxel—head and neck cancer	9.86e-05	0.0134	CcSEcCtD
Nateglinide—ALB—Folate Metabolism—TP53—head and neck cancer	9.85e-05	0.000865	CbGpPWpGaD
Nateglinide—Diarrhoea—Hydroxyurea—head and neck cancer	9.75e-05	0.0133	CcSEcCtD
Nateglinide—UGT1A9—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	9.58e-05	0.000841	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	9.49e-05	0.000833	CbGpPWpGaD
Nateglinide—Dizziness—Hydroxyurea—head and neck cancer	9.43e-05	0.0129	CcSEcCtD
Nateglinide—Immune system disorder—Docetaxel—head and neck cancer	9.42e-05	0.0128	CcSEcCtD
Nateglinide—CYP2D6—Metabolism—UROD—head and neck cancer	9.39e-05	0.000825	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—UROD—head and neck cancer	9.31e-05	0.000818	CbGpPWpGaD
Nateglinide—Nausea—Vinblastine—head and neck cancer	9.29e-05	0.0127	CcSEcCtD
Nateglinide—ABCC8—Neuronal System—HRAS—head and neck cancer	9.22e-05	0.00081	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—DPYD—head and neck cancer	9.21e-05	0.000809	CbGpPWpGaD
Nateglinide—Malnutrition—Docetaxel—head and neck cancer	9.08e-05	0.0124	CcSEcCtD
Nateglinide—Vomiting—Hydroxyurea—head and neck cancer	9.06e-05	0.0124	CcSEcCtD
Nateglinide—Dyspepsia—Fluorouracil—head and neck cancer	9.03e-05	0.0123	CcSEcCtD
Nateglinide—UGT1A9—Metabolism—NAT2—head and neck cancer	9.02e-05	0.000792	CbGpPWpGaD
Nateglinide—Rash—Hydroxyurea—head and neck cancer	8.99e-05	0.0123	CcSEcCtD
Nateglinide—PPARG—Circadian rythm related genes—TP53—head and neck cancer	8.98e-05	0.000789	CbGpPWpGaD
Nateglinide—Dermatitis—Hydroxyurea—head and neck cancer	8.98e-05	0.0122	CcSEcCtD
Nateglinide—KCNJ11—Neuronal System—HRAS—head and neck cancer	8.94e-05	0.000785	CbGpPWpGaD
Nateglinide—SLC16A1—Hemostasis—IL2—head and neck cancer	8.91e-05	0.000783	CbGpPWpGaD
Nateglinide—Gastrointestinal disorder—Fluorouracil—head and neck cancer	8.86e-05	0.0121	CcSEcCtD
Nateglinide—ALB—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	8.83e-05	0.000775	CbGpPWpGaD
Nateglinide—Back pain—Docetaxel—head and neck cancer	8.78e-05	0.012	CcSEcCtD
Nateglinide—PPARG—Metabolism—YAP1—head and neck cancer	8.74e-05	0.000767	CbGpPWpGaD
Nateglinide—ABCC4—Platelet activation, signaling and aggregation—PIK3CA—head and neck cancer	8.56e-05	0.000751	CbGpPWpGaD
Nateglinide—Nausea—Hydroxyurea—head and neck cancer	8.47e-05	0.0115	CcSEcCtD
Nateglinide—Urticaria—Fluorouracil—head and neck cancer	8.15e-05	0.0111	CcSEcCtD
Nateglinide—Palpitations—Docetaxel—head and neck cancer	8.02e-05	0.0109	CcSEcCtD
Nateglinide—Cough—Docetaxel—head and neck cancer	7.92e-05	0.0108	CcSEcCtD
Nateglinide—UGT1A9—Metabolism—DPYD—head and neck cancer	7.91e-05	0.000695	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	7.81e-05	0.000686	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	7.73e-05	0.000679	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—NAT2—head and neck cancer	7.59e-05	0.000666	CbGpPWpGaD
Nateglinide—SLC16A1—Hemostasis—VEGFA—head and neck cancer	7.57e-05	0.000665	CbGpPWpGaD
Nateglinide—Hypersensitivity—Fluorouracil—head and neck cancer	7.56e-05	0.0103	CcSEcCtD
Nateglinide—UGT1A9—Metabolism—YAP1—head and neck cancer	7.51e-05	0.000659	CbGpPWpGaD
Nateglinide—CYP3A4—Biological oxidations—GSTM1—head and neck cancer	7.36e-05	0.000647	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—NAT2—head and neck cancer	7.36e-05	0.000646	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—TYMS—head and neck cancer	7.32e-05	0.000643	CbGpPWpGaD
Nateglinide—CYP3A4—Metapathway biotransformation—GSTM1—head and neck cancer	7.26e-05	0.000638	CbGpPWpGaD
Nateglinide—Pruritus—Fluorouracil—head and neck cancer	7.26e-05	0.0099	CcSEcCtD
Nateglinide—ABCC8—Metabolism—GSTM1—head and neck cancer	7.24e-05	0.000635	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	7.22e-05	0.000634	CbGpPWpGaD
Nateglinide—SLC16A1—Hemostasis—MAPK3—head and neck cancer	7.17e-05	0.000629	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—TYMS—head and neck cancer	7.1e-05	0.000623	CbGpPWpGaD
Nateglinide—Diarrhoea—Fluorouracil—head and neck cancer	7.02e-05	0.00958	CcSEcCtD
Nateglinide—KCNJ11—Metabolism—GSTM1—head and neck cancer	7.02e-05	0.000616	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—TYMS—head and neck cancer	7e-05	0.000614	CbGpPWpGaD
Nateglinide—ABCC4—Platelet activation, signaling and aggregation—AKT1—head and neck cancer	6.99e-05	0.000614	CbGpPWpGaD
Nateglinide—CYP3A4—Biological oxidations—CYP1A1—head and neck cancer	6.98e-05	0.000613	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—GPX1—head and neck cancer	6.93e-05	0.000609	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—GSTM1—head and neck cancer	6.92e-05	0.000607	CbGpPWpGaD
Nateglinide—CYP3A4—Metapathway biotransformation—CYP1A1—head and neck cancer	6.89e-05	0.000605	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—CYP1A1—head and neck cancer	6.86e-05	0.000602	CbGpPWpGaD
Nateglinide—SLC16A1—Hemostasis—MAPK1—head and neck cancer	6.82e-05	0.000599	CbGpPWpGaD
Nateglinide—Dizziness—Fluorouracil—head and neck cancer	6.79e-05	0.00925	CcSEcCtD
Nateglinide—KCNJ11—Metabolism—GPX1—head and neck cancer	6.72e-05	0.00059	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—DPYD—head and neck cancer	6.65e-05	0.000584	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—CYP1A1—head and neck cancer	6.65e-05	0.000584	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—IL2—head and neck cancer	6.65e-05	0.000584	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—GPX1—head and neck cancer	6.62e-05	0.000582	CbGpPWpGaD
Nateglinide—PPARG—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	6.56e-05	0.000576	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—CYP1A1—head and neck cancer	6.56e-05	0.000576	CbGpPWpGaD
Nateglinide—Vomiting—Fluorouracil—head and neck cancer	6.52e-05	0.0089	CcSEcCtD
Nateglinide—Dyspepsia—Docetaxel—head and neck cancer	6.52e-05	0.00889	CcSEcCtD
Nateglinide—Rash—Fluorouracil—head and neck cancer	6.47e-05	0.00882	CcSEcCtD
Nateglinide—Dermatitis—Fluorouracil—head and neck cancer	6.46e-05	0.00882	CcSEcCtD
Nateglinide—PTGS1—Metabolism—DPYD—head and neck cancer	6.45e-05	0.000566	CbGpPWpGaD
Nateglinide—Gastrointestinal disorder—Docetaxel—head and neck cancer	6.39e-05	0.00872	CcSEcCtD
Nateglinide—Fatigue—Docetaxel—head and neck cancer	6.39e-05	0.00871	CcSEcCtD
Nateglinide—CYP3A7—Metabolism—YAP1—head and neck cancer	6.31e-05	0.000554	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—UROD—head and neck cancer	6.14e-05	0.000539	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—YAP1—head and neck cancer	6.12e-05	0.000537	CbGpPWpGaD
Nateglinide—Nausea—Fluorouracil—head and neck cancer	6.1e-05	0.00831	CcSEcCtD
Nateglinide—Gastrointestinal pain—Docetaxel—head and neck cancer	6.06e-05	0.00826	CcSEcCtD
Nateglinide—SLC16A1—Hemostasis—PIK3CA—head and neck cancer	5.92e-05	0.00052	CbGpPWpGaD
Nateglinide—Abdominal pain—Docetaxel—head and neck cancer	5.85e-05	0.00798	CcSEcCtD
Nateglinide—ALB—Platelet activation, signaling and aggregation—IL2—head and neck cancer	5.83e-05	0.000512	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—VEGFA—head and neck cancer	5.79e-05	0.000508	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—STAT3—head and neck cancer	5.73e-05	0.000503	CbGpPWpGaD
Nateglinide—PPARG—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	5.73e-05	0.000503	CbGpPWpGaD
Nateglinide—SLC16A1—Hemostasis—TP53—head and neck cancer	5.72e-05	0.000503	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—VEGFA—head and neck cancer	5.65e-05	0.000496	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	5.64e-05	0.000495	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—NAT2—head and neck cancer	5.49e-05	0.000482	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—MAPK3—head and neck cancer	5.48e-05	0.000481	CbGpPWpGaD
Nateglinide—SLC16A1—Hemostasis—HRAS—head and neck cancer	5.47e-05	0.000481	CbGpPWpGaD
Nateglinide—Hypersensitivity—Docetaxel—head and neck cancer	5.46e-05	0.00744	CcSEcCtD
Nateglinide—ABCC4—Hemostasis—MAPK3—head and neck cancer	5.34e-05	0.000469	CbGpPWpGaD
Nateglinide—Asthenia—Docetaxel—head and neck cancer	5.31e-05	0.00725	CcSEcCtD
Nateglinide—PPARG—Metabolism—TYMS—head and neck cancer	5.25e-05	0.000461	CbGpPWpGaD
Nateglinide—Pruritus—Docetaxel—head and neck cancer	5.24e-05	0.00715	CcSEcCtD
Nateglinide—PPARG—Developmental Biology—MAPK1—head and neck cancer	5.21e-05	0.000458	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—EGFR—head and neck cancer	5.21e-05	0.000458	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—GSTM1—head and neck cancer	5.19e-05	0.000455	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—MAPK1—head and neck cancer	5.08e-05	0.000446	CbGpPWpGaD
Nateglinide—Diarrhoea—Docetaxel—head and neck cancer	5.07e-05	0.00691	CcSEcCtD
Nateglinide—PPARG—Gene Expression—NOTCH1—head and neck cancer	5.06e-05	0.000445	CbGpPWpGaD
Nateglinide—ALB—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	5.02e-05	0.000441	CbGpPWpGaD
Nateglinide—ALB—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	4.97e-05	0.000436	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—GPX1—head and neck cancer	4.97e-05	0.000436	CbGpPWpGaD
Nateglinide—ALB—Platelet activation, signaling and aggregation—VEGFA—head and neck cancer	4.96e-05	0.000435	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	4.92e-05	0.000432	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—CYP1A1—head and neck cancer	4.92e-05	0.000432	CbGpPWpGaD
Nateglinide—Dizziness—Docetaxel—head and neck cancer	4.9e-05	0.00668	CcSEcCtD
Nateglinide—SLC16A1—Hemostasis—AKT1—head and neck cancer	4.83e-05	0.000424	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—DPYD—head and neck cancer	4.81e-05	0.000422	CbGpPWpGaD
Nateglinide—ALB—Metabolism—NAT2—head and neck cancer	4.72e-05	0.000415	CbGpPWpGaD
Nateglinide—Vomiting—Docetaxel—head and neck cancer	4.71e-05	0.00642	CcSEcCtD
Nateglinide—ALB—Platelet activation, signaling and aggregation—MAPK3—head and neck cancer	4.69e-05	0.000412	CbGpPWpGaD
Nateglinide—Rash—Docetaxel—head and neck cancer	4.67e-05	0.00637	CcSEcCtD
Nateglinide—Dermatitis—Docetaxel—head and neck cancer	4.67e-05	0.00636	CcSEcCtD
Nateglinide—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	4.6e-05	0.000404	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—YAP1—head and neck cancer	4.56e-05	0.000401	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—TYMS—head and neck cancer	4.51e-05	0.000396	CbGpPWpGaD
Nateglinide—ALB—Platelet activation, signaling and aggregation—MAPK1—head and neck cancer	4.46e-05	0.000392	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—GSTM1—head and neck cancer	4.46e-05	0.000391	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—PIK3CA—head and neck cancer	4.41e-05	0.000387	CbGpPWpGaD
Nateglinide—Nausea—Docetaxel—head and neck cancer	4.4e-05	0.006	CcSEcCtD
Nateglinide—UGT1A9—Metabolism—GPX1—head and neck cancer	4.27e-05	0.000375	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—TP53—head and neck cancer	4.27e-05	0.000375	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—CYP1A1—head and neck cancer	4.22e-05	0.000371	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—HRAS—head and neck cancer	4.18e-05	0.000367	CbGpPWpGaD
Nateglinide—ALB—Metabolism—DPYD—head and neck cancer	4.14e-05	0.000364	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	4.11e-05	0.000361	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—HRAS—head and neck cancer	4.08e-05	0.000358	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—PTGS2—head and neck cancer	4.08e-05	0.000358	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	4.07e-05	0.000357	CbGpPWpGaD
Nateglinide—PPARG—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	4.04e-05	0.000355	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	4.01e-05	0.000352	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—PTGS2—head and neck cancer	3.96e-05	0.000347	CbGpPWpGaD
Nateglinide—ALB—Metabolism—YAP1—head and neck cancer	3.93e-05	0.000345	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—NAT2—head and neck cancer	3.9e-05	0.000343	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—PTGS2—head and neck cancer	3.9e-05	0.000342	CbGpPWpGaD
Nateglinide—ALB—Platelet activation, signaling and aggregation—PIK3CA—head and neck cancer	3.87e-05	0.00034	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—NAT2—head and neck cancer	3.87e-05	0.00034	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—TYMS—head and neck cancer	3.79e-05	0.000333	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—GSTM1—head and neck cancer	3.75e-05	0.000329	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—AKT1—head and neck cancer	3.69e-05	0.000324	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—TYMS—head and neck cancer	3.68e-05	0.000323	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—GSTM1—head and neck cancer	3.63e-05	0.000319	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—AKT1—head and neck cancer	3.6e-05	0.000316	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—GPX1—head and neck cancer	3.59e-05	0.000315	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—PTEN—head and neck cancer	3.56e-05	0.000312	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—CYP1A1—head and neck cancer	3.55e-05	0.000312	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—GPX1—head and neck cancer	3.48e-05	0.000306	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	3.47e-05	0.000305	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—PTEN—head and neck cancer	3.45e-05	0.000303	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—CYP1A1—head and neck cancer	3.44e-05	0.000302	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—DPYD—head and neck cancer	3.42e-05	0.0003	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—PTEN—head and neck cancer	3.4e-05	0.000299	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—DPYD—head and neck cancer	3.39e-05	0.000298	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—YAP1—head and neck cancer	3.25e-05	0.000285	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—YAP1—head and neck cancer	3.22e-05	0.000283	CbGpPWpGaD
Nateglinide—ALB—Platelet activation, signaling and aggregation—AKT1—head and neck cancer	3.16e-05	0.000278	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—IL2—head and neck cancer	3.01e-05	0.000264	CbGpPWpGaD
Nateglinide—ALB—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	2.95e-05	0.000259	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—PTGS2—head and neck cancer	2.92e-05	0.000257	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	2.83e-05	0.000248	CbGpPWpGaD
Nateglinide—PPARG—Gene Expression—MAPK3—head and neck cancer	2.8e-05	0.000246	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—TYMS—head and neck cancer	2.74e-05	0.000241	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—GSTM1—head and neck cancer	2.71e-05	0.000238	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—GPX1—head and neck cancer	2.59e-05	0.000228	CbGpPWpGaD
Nateglinide—ALB—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	2.58e-05	0.000226	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—CYP1A1—head and neck cancer	2.57e-05	0.000226	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—VEGFA—head and neck cancer	2.56e-05	0.000224	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—NAT2—head and neck cancer	2.55e-05	0.000224	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—PTEN—head and neck cancer	2.55e-05	0.000224	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—PTGS2—head and neck cancer	2.51e-05	0.000221	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—PIK3CA—head and neck cancer	2.51e-05	0.00022	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—PIK3CA—head and neck cancer	2.43e-05	0.000214	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	2.42e-05	0.000212	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—MAPK3—head and neck cancer	2.42e-05	0.000212	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—PIK3CA—head and neck cancer	2.4e-05	0.000211	CbGpPWpGaD
Nateglinide—ALB—Metabolism—TYMS—head and neck cancer	2.36e-05	0.000207	CbGpPWpGaD
Nateglinide—ALB—Metabolism—GSTM1—head and neck cancer	2.33e-05	0.000205	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—MAPK1—head and neck cancer	2.3e-05	0.000202	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—DPYD—head and neck cancer	2.24e-05	0.000196	CbGpPWpGaD
Nateglinide—ALB—Metabolism—GPX1—head and neck cancer	2.23e-05	0.000196	CbGpPWpGaD
Nateglinide—ALB—Metabolism—CYP1A1—head and neck cancer	2.21e-05	0.000194	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—PTEN—head and neck cancer	2.19e-05	0.000192	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—YAP1—head and neck cancer	2.12e-05	0.000186	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—PTGS2—head and neck cancer	2.11e-05	0.000186	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	2.11e-05	0.000185	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—AKT1—head and neck cancer	2.05e-05	0.00018	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—PTGS2—head and neck cancer	2.05e-05	0.00018	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—PIK3CA—head and neck cancer	2e-05	0.000175	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—AKT1—head and neck cancer	1.99e-05	0.000175	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—AKT1—head and neck cancer	1.96e-05	0.000172	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—TYMS—head and neck cancer	1.95e-05	0.000171	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—TYMS—head and neck cancer	1.93e-05	0.00017	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—TP53—head and neck cancer	1.93e-05	0.00017	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—GSTM1—head and neck cancer	1.93e-05	0.000169	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—GSTM1—head and neck cancer	1.91e-05	0.000168	CbGpPWpGaD
Nateglinide—PPARG—Gene Expression—AKT1—head and neck cancer	1.89e-05	0.000166	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—HRAS—head and neck cancer	1.85e-05	0.000162	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—GPX1—head and neck cancer	1.84e-05	0.000162	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—PTEN—head and neck cancer	1.84e-05	0.000162	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—GPX1—head and neck cancer	1.83e-05	0.000161	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—CYP1A1—head and neck cancer	1.83e-05	0.00016	CbGpPWpGaD
Nateglinide—ALB—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.82e-05	0.00016	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—CYP1A1—head and neck cancer	1.81e-05	0.000159	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—PIK3CA—head and neck cancer	1.8e-05	0.000158	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—PTEN—head and neck cancer	1.79e-05	0.000157	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—AKT1—head and neck cancer	1.63e-05	0.000143	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—PIK3CA—head and neck cancer	1.55e-05	0.000136	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—PTGS2—head and neck cancer	1.53e-05	0.000134	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.49e-05	0.000131	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—AKT1—head and neck cancer	1.47e-05	0.000129	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—PTEN—head and neck cancer	1.33e-05	0.000117	CbGpPWpGaD
Nateglinide—ALB—Metabolism—PTGS2—head and neck cancer	1.32e-05	0.000116	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—PIK3CA—head and neck cancer	1.3e-05	0.000114	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—TYMS—head and neck cancer	1.27e-05	0.000112	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—AKT1—head and neck cancer	1.26e-05	0.000111	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—PIK3CA—head and neck cancer	1.26e-05	0.000111	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—GSTM1—head and neck cancer	1.26e-05	0.000111	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—GPX1—head and neck cancer	1.21e-05	0.000106	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—CYP1A1—head and neck cancer	1.19e-05	0.000105	CbGpPWpGaD
Nateglinide—ALB—Metabolism—PTEN—head and neck cancer	1.15e-05	0.000101	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—PTGS2—head and neck cancer	1.09e-05	9.54e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—PTGS2—head and neck cancer	1.08e-05	9.45e-05	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—AKT1—head and neck cancer	1.06e-05	9.33e-05	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—AKT1—head and neck cancer	1.03e-05	9.04e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—PTEN—head and neck cancer	9.47e-06	8.32e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—PIK3CA—head and neck cancer	9.4e-06	8.25e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—PTEN—head and neck cancer	9.39e-06	8.25e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—PIK3CA—head and neck cancer	8.09e-06	7.11e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—AKT1—head and neck cancer	7.68e-06	6.74e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—PTGS2—head and neck cancer	7.1e-06	6.24e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—PIK3CA—head and neck cancer	6.68e-06	5.87e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—PIK3CA—head and neck cancer	6.62e-06	5.82e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—AKT1—head and neck cancer	6.61e-06	5.81e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—PTEN—head and neck cancer	6.19e-06	5.44e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—AKT1—head and neck cancer	5.46e-06	4.79e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—AKT1—head and neck cancer	5.41e-06	4.75e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—PIK3CA—head and neck cancer	4.37e-06	3.84e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—AKT1—head and neck cancer	3.57e-06	3.13e-05	CbGpPWpGaD
